Alyssa Levin
Finanzdirektor/CFO bei NKARTA, INC.
Vermögen: - $ am 31.05.2024
Profil
Alyssa Levin is currently the Chief Financial & Business Officer at Nkarta, Inc. She previously worked as the Chief Financial Officer at ViaCyte, Inc. and Bird Rock Bio Sub, Inc. She also served as the Chief Financial Officer & Senior VP-Operations at Tentarix Biotherapeutics, Inc. Ms. Levin completed her undergraduate degree at the University of British Columbia and her graduate degree at Edwards School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NKARTA, INC.
-.--% | 15.04.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Alyssa Levin
Unternehmen | Position | Beginn |
---|---|---|
NKARTA, INC. | Finanzdirektor/CFO | 05.07.2023 |
Ehemalige bekannte Positionen von Alyssa Levin
Unternehmen | Position | Ende |
---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 05.07.2023 |
Tentarix Biotherapeutics, Inc. | Finanzdirektor/CFO | 02.01.2022 |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Finanzdirektor/CFO | 02.01.2020 |
Ausbildung von Alyssa Levin
University of British Columbia | Undergraduate Degree |
Edwards School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NKARTA, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Tentarix Biotherapeutics, Inc. |